<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04864015</url>
  </required_header>
  <id_info>
    <org_study_id>s65197</org_study_id>
    <nct_id>NCT04864015</nct_id>
  </id_info>
  <brief_title>COVID-19 Aerosol in EGD Using a Droplet Reduction Mouthpiece</brief_title>
  <official_title>COVID-19: a Study About Aerosol Formation During Gastroscopy With a Adjusted Mouthpiece for Droplet Reduction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Measurement of aerosolisation during esophagogastroduodenoscopy (EGD) to compare two types of&#xD;
      mouthpieces, conventional versus a new and commercially available one 'the droplet reduction&#xD;
      mouthpiece B1'.&#xD;
&#xD;
      This new mouthpiece is considered to reduce droplet spreading during EGD and therefore could&#xD;
      be a good option for use in COVID-19 positive patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During esophagogastroduodenoscopy (EGD), a hard-plastic mouthpiece is used to protect the&#xD;
      endoscope from being bitten and to enable its smooth insertion. In September 2020, the&#xD;
      droplet reduction Mouthpiece &quot;B1&quot; (Mouthpiece MPC-ST GMDN:62534 Generic name: Endoscopic bite&#xD;
      block, basic, reusable) was launched by Fujifilm Corporation, Tokyo, Japan and imported to&#xD;
      Europe by Fujifilm Europe. The droplet reduction mouthpiece is used in the same way as the&#xD;
      conventional mouthpiece but differs from current mouthpieces by the inclusion of a sponge&#xD;
      rubber incorporated into the mouthpiece orifice, and a drape shield specifically created to&#xD;
      catch and reduce the droplets emitted by the patient during upper gastrointestinal endoscopy.&#xD;
      This newly developed mouthpiece is considered for application during routine endoscopy at our&#xD;
      facility during the COVID-19 pandemic, helping to minimize the risk to health care workers&#xD;
      and patients from becoming infected with COVID-19 and various other pathogens. However, there&#xD;
      is a lack of scientific evidence on the amount of aerosol reduction with the modified&#xD;
      mouthpiece when upper gastrointestinal (GI) endoscopy is being performed.&#xD;
&#xD;
      The aim of the present study is to quantify the generation of aerosols when performing upper&#xD;
      GI endoscopy with the modified mouthpiece. The investigators intend to quantify the number of&#xD;
      particles in the air near the patient. The duration of therapeutic upper gastrointestinal&#xD;
      endoscopies can vary extremely. To avoid risk of imbalance in procedure durations, the&#xD;
      investigational team is limiting the protocol to standard diagnostic EGDs. The investigators&#xD;
      assume that aerosol generations during short procedures can be extrapolated to longer&#xD;
      procedures and hence this should not invalidate the findings&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 17, 2021</start_date>
  <completion_date type="Actual">June 30, 2021</completion_date>
  <primary_completion_date type="Actual">May 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A investigator-initiated single center open-label randomized trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Generation of aerosol particles by esophagogastroduodenoscopy with the droplet reduction mouthpiece.</measure>
    <time_frame>4 months</time_frame>
    <description>Number of aerosols generated by EGD with the droplet reduction mouthpiece</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Droplet Spread</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Conventional mouthpiece</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients undergoing standard EGD using a conventional mouthpiece</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Droplet reduction mouthpiece</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing standard EGD using a new droplet reduction mouthpiece</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mouthpiece B1(Mouthpiece MPC-ST GMDN:62534 Generic name: Endoscopic bite block, basic, reusable</intervention_name>
    <description>Use of a Mouthpiece B1 during standard EGD instead of a conventional mouthpiece</description>
    <arm_group_label>Conventional mouthpiece</arm_group_label>
    <arm_group_label>Droplet reduction mouthpiece</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged &gt;18 years old;&#xD;
&#xD;
          -  Male or female patients;&#xD;
&#xD;
          -  Patients undergoing elective standard diagnostic EGD;&#xD;
&#xD;
          -  Negative polymerase chain reaction (PCR) test on nasopharyngeal swab 24 or 48 hours&#xD;
             prior to the test;&#xD;
&#xD;
          -  No anatomical deformity of nose and throat, no known diseases of nose and throat;&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Females who are pregnant or lactating.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Tack, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven, KU Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raf Bisschops, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven, KU Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Flemish Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 27, 2021</study_first_submitted>
  <study_first_submitted_qc>April 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>droplet reduction mask</keyword>
  <keyword>COVID-19</keyword>
  <keyword>upper GI endoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We won't share individual participant data</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 4, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT04864015/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 2, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT04864015/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

